- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01454414
Tick-borne Illness and Clothing Study (TICS)
March 9, 2021 updated by: University of North Carolina, Chapel Hill
Preventing Exposure to Ticks and Tick-borne Illness in Outdoor Workers
The high risk of acquiring tick-borne diseases by outdoor workers is well documented.
Workers most at risk include, foresters, park rangers, land surveyors and other outdoor workers have frequent exposure to tick-infested habitats.
Many North Carolina state employees with outdoor occupations report multiple tick bites each year, which indicates that existing tick preventive strategies may be ineffective.
The principal goal of this study is to assess whether the use of long-lasting permethrin impregnated uniforms can reduce the number of tick bites sustained by North Carolina outdoor workers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
159
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Gillings School of Global Public Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being over 18 years of age
- Employee of NC Division of Forest Resources, the NC Division of Parks and Recreation, NC Wildlife Resources Commission, or NC County and Local Parks and Recreation who work in Central and Eastern North Carolina
- An average of 10 or more hours of outdoor work per week during tick season
- Self-reported prior work-related tick bites
Exclusion Criteria:
- Pregnancy
- Non-English speaking
- Known allergy to insecticides
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Permethrin Impregnated Uniforms
Uniforms (including pants, shorts, shirts, socks, and hats) treated with long-lasting permethrin.
|
Uniforms treated with permethrin according to proprietary process used by Insect Shield, Inc.
Other Names:
|
|
No Intervention: Placebo
Uniforms sent to Insect Shield, washed and refolded (no permethrin applied).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Work Related Tick Bites
Time Frame: Weekly for two years
|
Tick bites are defined as ticks attached to or embedded in the skin
|
Weekly for two years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Seroconversion Against a Tick-borne Illness
Time Frame: Upon enrollment, after the first year, and after the second year
|
We will define seroconversion as one in which there is a 4-fold change in Immunoglobulin G class antibody titer between sera at enrollment, sera obtained after one year and/or sera obtained at study's end or between acute and convalescent sera for participants developing an acute illness.
The antigens that will be used in the serologic assays include Ehrlichia chaffeensis (which would also detect antibodies to E. ewingii and Anaplasma phagocytophilum) and Rickettsia rickettsii (which would also detect antibodies to other spotted fever group rickettsiae).
|
Upon enrollment, after the first year, and after the second year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Steven R Meshnick, MD, PhD, University of North Carolina, Chapel Hill
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
April 1, 2013
Study Registration Dates
First Submitted
October 10, 2011
First Submitted That Met QC Criteria
October 15, 2011
First Posted (Estimate)
October 19, 2011
Study Record Updates
Last Update Posted (Actual)
March 30, 2021
Last Update Submitted That Met QC Criteria
March 9, 2021
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-1027
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tick Bites
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Active, not recruitingTick Bites | Tick ResistanceNetherlands
-
University of North Carolina, Chapel HillNational Institute for Occupational Safety and Health (NIOSH/CDC); East Carolina... and other collaboratorsCompletedTick Bites | Tick-borne DiseasesUnited States
-
Luxembourg Institute of HealthCentre Hospitalier du Luxembourg; Luxembourg National Research Fund (FNR)RecruitingAlpha-Gal SyndromeLuxembourg
-
ARCTECCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedTick Bites | Immunity to TicksNetherlands
-
University of Wisconsin, MadisonColumbia University; University of Illinois at Chicago; Washington State University and other collaboratorsRecruiting
-
University Hospital, Strasbourg, FranceRecruitingTick-borne Encephalitis, FranceFrance
-
National Institute of Allergy and Infectious Diseases...RecruitingLyme Disease | Tick-borne Diseases | Tick ResistanceUnited States
-
Göteborg UniversityVastra Gotaland Region; Sahlgrenska University HospitalWithdrawnTick-Borne Diseases | Encephalitis, Tick-Borne | Tick Bites | Tick-Bite; Fever | Tick FeverSweden
-
University Hospital, Strasbourg, FranceRecruiting
Clinical Trials on Permethrin Impregnated Uniforms
-
Assistance Publique Hopitaux De MarseilleTerminated
-
University of North Carolina, Chapel HillNational Institute for Occupational Safety and Health (NIOSH/CDC); East Carolina... and other collaboratorsCompletedTick Bites | Tick-borne DiseasesUnited States
-
Ifakara Health InstituteWalter Reed Army Institute of Research (WRAIR); Swiss Tropical & Public Health... and other collaboratorsUnknown
-
College of Physicians and Surgeons PakistanNot yet recruiting
-
Infectopharm Arzneimittel GmbHWinicker Norimed GmbHNot yet recruiting
-
London School of Hygiene and Tropical MedicineFederal Minstry of Health of Ethiopia; Oromia Regional Health Bureau, Ethiopia and other collaboratorsCompletedTrachomaUnited Kingdom, Ethiopia
-
Damascus UniversityUniversity of Aleppo; Tishreen University HospitalCompleted
-
Saptalis Pharmaceuticals LLCbioRASI, LLCCompleted
-
Medline IndustriesTerminatedWound Heal | Necrotic Tissue RemovalUnited States
-
Mylan Inc.Vyne Therapeutics Inc.; DPT Laboratories, Ltd.CompletedScabiesUnited States, Dominican Republic, Honduras, Puerto Rico